Hilar Cholangiocarcinoma — Trials

Hilar Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05564403	Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)	active not recruiting	Phase 2	66	National Cancer Institute (NCI)NIH	1	Aug 4, 2026	clinicaltrials
NCT06178588	Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma	active not recruiting	Phase 2	15	University of Kansas Medical CenterOTHER	1	Feb 24, 2026